New study aims to improve clinical trials for Wheelchair-Using FSHD patients
NCT ID NCT05453461
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study is for people with Facioscapulohumeral Muscular Dystrophy (FSHD) who use a wheelchair daily or can only walk a few steps. The goal is to test new methods, like muscle strength tests and motor function assessments, to see how well they track the disease over two years. By finding better ways to measure progression in severely affected patients, researchers hope to make future drug trials more effective for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Nice
Nice, Alpes Maritimes, 06000, France
Conditions
Explore the condition pages connected to this study.